期刊文献+

依维莫司联合顺铂对人胃癌SGC7901细胞凋亡及Bcl-2、Bax表达的影响 被引量:4

Effects of everolimus combined with cisplatin on apoptosis and Bcl-2,Bax expression of human gastric cancer SGC7901 cells
暂未订购
导出
摘要 目的探讨依维莫司(RAD001)联合顺铂对人胃癌SGC7901细胞凋亡及Bcl-2、Bax表达的影响。方法体外培养SGC7901细胞,将其分为对照组,顺铂组(顺铂2.50 mg/L),RAD001低浓度组(RAD001 5.00nmol/L)、RAD001中浓度组(RAD001 10.00nmol/L)、RAD001高浓度组(RAD001 20.00nmol/L)及联合组(顺铂1.25mg/L+RAD001 5.00nmol/L),采用流式细胞术检测SGC7901细胞的凋亡率,采用免疫细胞化学、Western blot检测SGC7901细胞Bcl-2和Bax的表达情况。结果 RAD001、顺铂作用SGC7901细胞48h后,对照组,顺铂组,RAD001低、中、高浓度组及联合组的细胞凋亡率分别为(8.04±0.48)%、(18.94±0.75)%、(10.47±1.05)%、(13.93±2.45)%、(17.20±0.65)%及(23.18±1.05)%。除RAD001低浓度组细胞凋亡率与对照组比较,差异无统计学意义(P>0.05),其他各组细胞凋亡率均较对照组显著增加(P<0.05)。与对照组比较,顺铂组、RAD001组及联合组SGC7901细胞Bcl-2蛋白表达下降,而Bax蛋白表达增加,Bcl-2/Bax比值降低(P<0.05),联合组改变最明显。结论 RAD001联合顺铂可通过上调Bax和下调Bcl-2蛋白的表达诱导SGC7901细胞凋亡。 Abstract:Objective To investigate everolimus(RAD001) combined with cisplatin on apoptosis and Bcl-2, Bax expression of human gastric cancer SGC7901 cells. Methods SGC7901 cells were cultured in vitro and divided into control group,cisplatin group (cisplatin 2.50 mg/L),RAD001 low concentration group(RAD001 5.00 nmol/L),RAD001 medium concentration group(RAD001 10.00 nmol/L), RAD001 high concentration group (RAD001 20. 00 nmol/L) and combination group (cisplatin 1. 25 mg/L-+ RAD001 5.00 nmol/L). Flow cytometry was employed to detect apoptotic rate of SGC7901 cells and immunocytochemistry and Western blot were conducted to measure Bcl-2,Bax expression of SGC7901 cells. Results After 48 h treatment,apoptotic rates of SGC7901 cells in control group, cisplatin group, RADO01 low concentration group, RAD001 medium concentration group, RAD001 high concentration group and combination group were (8.04 ± 0.48 ) %, ( 18.94 ± 0.75) %, ( 10.47 ± 1.05 ) %, ( 13.93 ± 2.45 ) %, (17.20± 0.65) % and (23. 18± 1.05)%. Except RAD001 low concentration group showing no statistically significant difference when compared to control group, the apoptotic rates in the other groups were obviously increased(P〈0.05). Compared with con- trol group,SGC7901 cells in cisplatin group,RAD001 groups and combination group showed decreasing Bcl-2 and increasing Bax protein expression,and lower Bcl-2/Bax ratio(P〈0.05). Changes in combination group were the most obvious. Conclusion RAD001 combined with cisplatin can induce apoptosis in SGC7901 ceils via up-regulating Pax and down-regulating Bcl-2 protein expression.
出处 《重庆医学》 CAS CSCD 北大核心 2013年第2期138-142,共5页 Chongqing medicine
关键词 细胞凋亡 基因 BCL-2 基因 bax 顺铂 依维莫司 apoptosis genes, bcl-2 genes, bax cisplatin everolimus
  • 相关文献

参考文献3

二级参考文献38

  • 1王强,赵滢,张天彪,寇有为.survivin、PTEN在胃癌组织中的表达以及相关性[J].中国医科大学学报,2009,38(4):270-273. 被引量:10
  • 2李凤朝 ,孔庆兖 ,杨雪梅 .Survivin表达与胃癌细胞凋亡、增殖及肿瘤血管形成的关系[J].实用癌症杂志,2004,19(6):592-594. 被引量:8
  • 3陈樑,张红锋.mTOR信号通路与癌症治疗[J].生命的化学,2005,25(2):127-129. 被引量:7
  • 4Bjornsti MA,Houghton PJ.The TOR pathway:a target for cancer therapy[J].Nat Bey Cancer,2004,4 (5):335-348.
  • 5Beata H,Harald P,Martina L,et al.Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma[J].Clin Cancer Bes,2007,13(16):4795-4799.
  • 6Guertin DA,Sabatini DM.An expanding role for mTOR in cancer[J].Trends Mol Med,2005,11 (8):353-361.
  • 7Proud CG.Signalling to translation:how signal transduction pathways control the protein synthetic machinery[J].Biochem J,2007,403(2):217-234.
  • 8Chan SM,Weng AP,Tibshirani R,et al.Notch signals positively regulate activity of the mTOR pathway in T cell acute lymphoblastic leukemia[J].Blood,2007,110 (1):278-286.
  • 9Martin JL,Baxter RC.Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway[J].Endocrinology,2007,148(5):2532-2541.
  • 10Nob WC,Kim YH,Kim MS,et al.Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables[J].Breast Cancer Res Treat,2008,110(3):477-483.

共引文献21

同被引文献43

  • 1鞠艳芳,焦顺昌.依维莫司治疗晚期非小细胞肺癌的临床观察[J].中国临床实用医学,2014(4):10-12. 被引量:1
  • 2Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5) :277-300.
  • 3Huang Z, Wu Y, Zhou X, et al. Clinical efficacy of mTOR in- hibitors in solid tumors: a systematic review[ J]. Future Oncol, 2015, 11(11) :1687-1699.
  • 4Bellmunt J, Werner L, Leow JJ, et al. Somatic copy number ab- normalities and mutations in PI3K/AKT/mTOR pathway have prognostic significance for overall survival in platinum treated lo- cally advanced or metastatic urothelial tumors [ J/OL ]. PLoS One, 2015 [ 2015-06-22 ]. http ://www. ncbi. nlm. nih. gov/pmc/ articles/pmid/26039708.
  • 5Zhang L, Wu J, Ling MT, et al. The role of the PI3K/Akt/ mTOR signalling pathway in human cancers induced by infection with human papillomaviruses[ J]. Mol Cancer, 2015, 14( 1 ) :87.
  • 6Panzuto F, Rinzivillo M, Fazio N, et al. Real-world study of everolimus in advanced progressive neuroendocrine tumors [ J ]. Oncologist, 2015, 20(5) : 570.
  • 7Pignochino Y, Dell'Aglio C, Inghilleri S, et al. The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma[ J/OL]. BMC Cancer, 2015 [ 2015 -06-20 ]. http ://www. ncbi. nlm. nih. gov/pubmed/25- 952930.
  • 8Sofia JC, Shepherd FA, Douillard JY, et al. Efficacy of everoli- mus( RADO01 ) in patients with advanced NSCLC previously trea- ted with chemotherapy alone or with chemotherapy and EGFR in- hibitors[ J]. Ann Oncol, 2009, 20(10) : 1674-1681.
  • 9Chen M, Du Y, Qui M, et al. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Aktsignaling pathway[ J:. Oncol Rep, 2013, 29 (2) : 430 -436.
  • 10Bendinelli P, Maroni P, Matteucci E, et al. HGF and TGFI31 differently influenced Wwox regulatory function on Twist program formesenchymal-epithelial transition in bone metastatic versus pa- rental breast carcinoma cells[ J/OL]. Mol Cancer, 20155[ 2015- 06-201. http ://www.ncbi.nlm.nih.gov/pubmed/26041563#.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部